Navigation Links
BCC Research Publishes a New Report on Separation Systems for Commercial Biotechnology Markets
Date:9/15/2013

Wellesley, MA (PRWEB) September 15, 2013

According to a new technical market research report, Separation Systems for Commercial Biotechnology from BCC Research (http://www.bccresearch.com), the global market for commercial biotechnology separation systems was valued at $16 billion in 2012 and is expected to reach $17.1 billion in 2013. BCC Research projects the market to reach nearly $27.8 billion by 2018, and register a compound annual growth rate (CAGR) of 10.1%.

As an application of commercial biotechnology, protein separation systems are playing an increasingly important role in new biopharmaceutical development. Protein separation systems do not require U.S. Food and Drug Administration (FDA) approval, but the products produced from these processes do, and they must be produced in accordance with FDA good manufacturing practices (GMP) guidelines. Thus, separation processes and equipment such as protein microarrays, lab-on-a-chip, biochips, DNA microarrays, flow cytometry and magnetic separation must pass FDA audits of the manufacturing process.

The biomolecule separation market is positioned for significant growth in the next five years. This is due to new protein and other biomolecule products that will require separation technology, as well as new innovations in the technology itself. The development of proteins as biotherapeutic agents against a number of human diseases by the biomedical and pharmaceutical industry is helping the industry achieve a higher growth rate. The recognition of this technology in emerging markets such as Japan and the Pacific Rim countries is also expected to contribute to further growth. In addition, continued global growth is expected to accrue as a result of the growing middle class in countries such as India, China, Brazil and Russia.

This comprehensive market analysis presents an overview of the global markets for biotechnology separation systems, and forecasts trends and sales in these markets through 2018. It also examines the separation process for a variety of biomolecules, including proteins, RNA, and DNA. This information will allow the reader to evaluate and quantify the current market size for specific separation systems within the growing biomedical and pharmaceutical technology market.

In addition, this report includes analysis of the leading competitors, as well as emerging companies in the current global biomolecule separation market. Profiles of the manufacturers are analyzed and their specific product strategies are outlined. This report notes companies that are poised to introduce new products during the forecast period and discusses how these products may change the face of the competitive environment. This competitive environment is examined with a special focus on the ways in which developing products and technologies are influencing the current standard of patient care.

This comprehensive technical market research report is an invaluable tool for business planners, acquisitions specialists, licensing strategists, product managers, market research analysts, investors, investor consultants, and anyone interested in the biomolecule separation market, its products, industry participants, and its future.

Read the full story at http://www.prweb.com/releases/2013/9/prweb11116810.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. UCLA Brain Injury Research Center gets NCAA funding for research on sports concussions
2. NIH awards $20 million over 5 years to train next generation of global health researchers
3. Researchers develop a new cell and animal model of inflammatory breast cancer
4. Researchers uncover a viable way for colorectal cancer patients to overcome drug resistance
5. Sexually abused boys at risk for more unsafe sex: UBC research
6. Researchers Find Gene Mutations That May Be a Key to Autism
7. LSUHSC research finds HPV-related head & neck cancers rising, highest in middle-aged white men
8. Researchers find evidence of banned antibiotics in poultry products
9. Presidential keynote address and new research highlights from the American Society of Pediatric Otolaryngology meeting
10. Scientific session and new research highlights
11. NJ stroke researchers report advances in spatial neglect research at AAN Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), one of ... innovative new design of the shoulder pad. The shoulder pad provides optimal support ... your pain while using cold therapy. By utilizing ice and water that is circulated ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... AccentCare, a leader in post-acute health care, have expanded their existing home health ... Home Health. , AccentCare has been operating a joint venture home health company ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... Hair Restoration, has recently contributed a medical article to the newly revamped ... Dr. Mohebi’s article spotlights the hair transplant procedure known as Follicular Unit ...
(Date:10/12/2017)... , ... October 12, 2017 , ... Leading pediatric oncology ... in Washington, D.C., for the 49th Congress of the International Society of Paediatric ... President of the Center for Cancer and Blood Disorders at Children’s National, ...
(Date:10/12/2017)... Mich. (PRWEB) , ... October 12, 2017 , ... ... has been named one of Michigan’s 2017 Best and Brightest in Wellness® by ... Brightest in Wellness® awards program on Friday, Oct. 20 from 7:30 a.m. to ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a leading global digital ... its MyDario product is expected to appear on The Dr. Oz Show ... Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. Oz Show kicked off ... The segment features ...
(Date:9/25/2017)...  EpiVax, Inc., a leader in the fields ... announced the launch of EpiVax Oncology Inc., a ... cancer vaccines. EpiVax has provided $500,000 in seed ... technologies to the new precision immunotherapy venture. Gad ... as Chief Executive Officer. Gad brings over 25 ...
(Date:9/22/2017)... ROCKVILLE, Md. , Sept. 22, 2017  As ... by Republican Senators Bill Cassidy (R-LA) and ... Kalorama Information notes that the medical device industry is ... the medical device tax, the 2.3% excise tax on ... Act.  But they also want covered patients, increased visits ...
Breaking Medicine Technology: